A Neurochemical Approach to the Search for Drugs for the Treatment of Symptoms of Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurochemical Journal

• Publication date

  2018-04-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1134/S1819712418010130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypothetical neurochemical mechanisms of paradoxical sleep deficiency in Alzheimer’s disease

  2017cited by this paper
• Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series.

  2017cited by this paper
• Melatonin receptors: distribution in mammalian brain and their respective putative functions

  2017cited by this paper
• Meta‐analysis of randomized, double‐blind, placebo‐controlled trials of melatonin in Alzheimer's disease

  2017cited by this paper
• Orexin and Alzheimer's Disease.

  2017cited by this paper
• Lateral hypothalamic circuits for sleep-wake control.

  2017cited by this paper
• Mechanisms of Melatonin in Alleviating Alzheimer’s Disease

  2017cited by this paper
• Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.

  2017cited by this paper
• Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders.

  2017cited by this paper
• The neuroprotective effects of caffeine in neurodegenerative diseases

  2017cited by this paper
• Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

  2017cited by this paper
• Wie Schlaf und Alzheimer-Krankheit zusammenhängen

  2016cited by this paper
• Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation

  2016cited by this paper
• Role of the Histamine H3 Receptor in the Central Nervous System.

  2016cited by this paper
• Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases.

  2016cited by this paper
• A Novel Population of Wake-Promoting GABAergic Neurons in the Ventral Lateral Hypothalamus.

  2016cited by this paper
• Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease.

  2016cited by this paper
• Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.

  2016cited by this paper
• Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies

  2016cited by this paper
• Neuronal histamine and cognitive symptoms in Alzheimer's disease.

  2016cited by this paper
• Interactions of the histamine and hypocretin systems in CNS disorders

  2015cited by this paper
• Schlafstörungen bei Demenzkranken

  2015cited by this paper
• Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain

  2015cited by this paper
• Centrally injected histamine increases posterior hypothalamic acetylcholine release in hemorrhage-hypotensive rats.

  2015cited by this paper
• Discovery of Multitarget-Directed Ligands against Alzheimer's Disease through Systematic Prediction of Chemical-Protein Interactions

  2015cited by this paper
• Optogenetic Evidence for Inhibitory Signaling from Orexin to MCH Neurons via Local Microcircuits

  2015cited by this paper
• Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103

  2015cited by this paper
• Nicotinic α4 Receptor-Mediated Cholinergic Influences on Food Intake and Activity Patterns in Hypothalamic Circuits

  2015cited by this paper
• Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.

  2014cited by this paper
• Alzheimer disease: Increased orexin level correlates with sleep disruption and cognitive decline in Alzheimer disease

  2014cited by this paper
• Histamine inhibits the melanin‐concentrating hormone system: implications for sleep and arousal

  2014cited by this paper
• Caffeine promotes glutamate and histamine release in the posterior hypothalamus.

  2014cited by this paper
• Brainstem projections of neurons located in various subdivisions of the dorsolateral hypothalamic area—an anterograde tract-tracing study

  2014cited by this paper
• A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.

  2014cited by this paper
• [Roles of adenosine receptors in Alzheimer's disease].

  2014cited by this paper
• Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin.

  2013cited by this paper
• The Neglected Role of Histamine in Alzheimer’s Disease

  2013cited by this paper
• Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.

  2013cited by this paper
• Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.

  2013cited by this paper
• Lateral hypothalamic GAD65 neurons are spontaneously firing and distinct from orexin‐ and melanin‐concentrating hormone neurons

  2013cited by this paper
• The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation.

  2013cited by this paper
• Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease

  2013cited by this paper
• hronic treatment with DCPCX , an adenosine A 1 antagonist , worsens ong-term memory

  2013cited by this paper
• Drugs for insomnia

  2012cited by this paper
• Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse

  2012cited by this paper
• Muscarinic receptors in brain stem and mesopontine cholinergic arousal functions.

  2012cited by this paper
• The Lateral Hypothalamic Area Controls Paradoxical (REM) Sleep by Means of Descending Projections to Brainstem GABAergic Neurons

  2012cited by this paper
• Retrograde study of projections from the tuberomammillary nucleus to the mesopontine cholinergic complex in the rat.

  2011cited by this paper
• Differential distribution of melanin-concentrating hormone (MCH)- and hypocretin (Hcrt)-immunoreactive neurons projecting to the mesopontine cholinergic complex in the rat.

  2011cited by this paper
• [Sleep disturbances in Alzheimer's disease and other dementias].

  2010cited by this paper
• Activation of the basal forebrain by the orexin/hypocretin neurones

  2010cited by this paper
• Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?

  2010cited by this paper
• A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats.

  2010cited by this paper
• Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats.

  2009cited by this paper
• Role of the melanin-concentrating hormone neuropeptide in sleep regulation.

  2009cited by this paper
• A role for Melanin-Concentrating Hormone in learning and memory.

  2009cited by this paper
• Regulation of Synaptic Efficacy in Hypocretin/Orexin-Containing Neurons by Melanin Concentrating Hormone in the Lateral Hypothalamus

  2008cited by this paper
• Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep

  2008cited by this paper
• Gene structures, biochemical characterization and distribution of rat melatonin receptors

  2008cited by this paper
• Sites et mécanismes d'action de la mélatonine chez les Mammifères: les récepteurs MT1 et MT2.

  2007cited by this paper
• Melatonin inhibits nicotinic currents in cultured rat cerebellar granule neurons

  2007cited by this paper
• High‐frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat

  2007cited by this paper
• A hypothetical mechanism for interactions between neuromodulators during paradoxical sleep

  2007cited by this paper
• Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect.

  2007cited by this paper
• Effects of melatonin on synaptic transmission and long-term potentiation in two areas of mouse hippocampus.

  2006cited by this paper
• The Effect of Sleep-Disordered Breathing on Stages of Sleep in Patients With Alzheimer's Disease

  2006cited by this paper
• Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.

  2006cited by this paper
• Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin‐releasing hormone

  2006cited by this paper
• GABA‐mediated control of hypocretin‐ but not melanin‐concentrating hormone‐immunoreactive neurones during sleep in rats

  2005cited by this paper
• LEEP AND CIRCADIAN ABNORMALITIES IN A TRANSGENIC MOUSE ODEL OF ALZHEIMER ’ S DISEASE : A ROLE FOR CHOLINERGIC

  2005cited by this paper
• Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.

  2005cited by this paper
• Melatonin inhibits hippocampal long‐term potentiation

  2005cited by this paper
• Stimulation of cortical acetylcholine release by orexin A.

  2005cited by this paper
• Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices.

  2005cited by this paper
• Adenosine A1 receptors mediate inhibition of cAMP formation in vitro in the pontine, REM sleep induction zone.

  2005cited by this paper
• The human pineal gland and melatonin in aging and Alzheimer's disease

  2005cited by this paper
• Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

  2003cited by this paper
• A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep

  2003cited by this paper
• Mammalian melatonin receptors: molecular biology and signal transduction

  2002cited by this paper
• Effects of orexin on the laterodorsal tegmental neurones

  2002cited by this paper
• Direct and Indirect Excitation of Laterodorsal Tegmental Neurons by Hypocretin/Orexin Peptides: Implications for Wakefulness and Narcolepsy

  2002cited by this paper
• Arousal effect of orexin A depends on activation of the histaminergic system

  2001cited by this paper
• Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus

  2001cited by this paper
• Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state.

  2000cited by this paper
• Age-related changes of neuronal counts in the human pedunculopontine nucleus.

  2000cited by this paper
• Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking.

  1999cited by this paper
• Histamine excites pedunculopontine neurones in guinea pig brainstem slices.

  1990cited by this paper

• No citing papers are available for this paper.